UT Southwestern Ranked No. 1 in Texas, Fourth in Nation for Tech Transfer
UT Southwestern Medical Center ranked fourth in the nation and No. 1 in Texas for commercializing new biomedical technologies
Source: newswise.com
📰 Recode Therapeutics News
Page 4 - Recode Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recode Therapeutics. Real-time updates on events, politics, business and more.
Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors
Investegate announcements from Prothena Corporation plc, Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors
Source: investegate.co.uk
Prothena Announces Appointment of Biotechnology Industry
DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust...
Source: globenewswire.com
The biggest US biotech investments in June 2022
In addition to recent Independence Day festivities, the U.S. biotech space has other reasons to celebrate. The asthma drug developer Upstream Bio topped the ranks for the U.S.’ biggest early-stage biotech investment in June 2022, but manufacturing heavyweight National Resilience, Inc. bagged the private funding top spot with a huge Series D round.
United States North Carolina San Francisco Rahul Singhvi National Resilience Inc National Resilience
Source: labiotech.eu
Bayer, Amgen join $120M financing for startup aiming to expand genetic meds delivery
In less than one year, ReCode Therapeutics has reeled in $200 million in financing. Big pharmaceutical companies are taking notice of the biotech startup’s technology, which enables lipid nanoparticles to go a wide range of organs and tissues, potentially broadening the reach of genetic medicines.
United States Menlo Park Alan Colowick David Lockhart Rakhshita Dhar University Of Texas Southwestern
Source: medcitynews.com
Nanoparticles Break Barriers Around Tumors and Target Cancer Cells
Solid tumors develop a strong, impenetrable molecular defensive wall around themselves as they enlarge. It is extremely difficult to get narcotics past the roadblock.
Daniel Siegwart Ut Southwestern Medical Center Postdoctoral Research Develop Nanoparticles Break Barriers Around Tumors Target Cancer
Source: azonano.com
The Global Negative Pressure Wound Therapy Market is Expected to Grow at a CAGR of 5.03% Reaching USD 4.28 Billion by 2026, Assesses DelveInsight
/PRNewswire/ -- According to the latest report published by DelveInsight "Negative Pressure Wound Therapy Market Insights," the global Negative Pressure Wound...
Source: prnewswire.com
DelveInsight Business Research, LLP: The Global Negative Pressure Wound Therapy Market is Expected to Grow at a CAGR of 5.03% Reaching USD 4.28 Billion by 2026, Assesses DelveInsight
As per DelveInsight Analysis in the Negative Pressure Wound Therapy market, the rising incidence of chronic wounds associated with various chronic disorders and also with the rising incidence
Source: finanznachrichten.de
The Tendonitis Market to Exhibit Growth at a CAGR of 2.9% In The 7MM During The Study Period (2018-30), Assesses DelveInsight
/PRNewswire/ -- DelveInsights Tendonitis Market Insights report includes a comprehensive understanding of current treatment practices, Tendonitis emerging...
United States United Kingdom Shruti Thakur Depuy Synthes Prnewswire Delveinsight Madison Depuy Synthes
Source: prnewswire.com
DelveInsight Business Research, LLP: The Tendonitis Market to Exhibit Growth at a CAGR of 2.9% In The 7MM During The Study Period (2018-30), Assesses DelveInsight
The tendonitis market is expected to grow significantly owing to an increase in the targeted patient pool and novel treatment approaches by the leading companies such as R3 Stem Cell, TRB Chemedica
United States United Kingdom Shruti Thakur Kostenloser Wertpapierhandel Depuy Synthes Prnewswire Delveinsight
Source: finanznachrichten.de